Farmak is among Ukraine’s best employers according to Forbes

Farmak, along with JTI, SoftServe, Fozzy Group and others, has been included in the list of 50 best employers of Ukraine compiled by the authoritative Forbes magazine and the Work.ua job search website.

The companies have been evaluated by the jury according to 23 indicators falling under the following 8 criteria:

1. Reputation and loyalty – the willingness of employees to recommend their company to their families and friends.
2. Remuneration – the level of net salary per month.
3. Working conditions – work schedule, number of sick days and duration of holidays, team spirit, workplace security, etc.
4. Social package – number of extra bonuses (health insurance, payment of some expenses, free participation in workshops and trainings, etc.)
5. Transparency – the availability of reports and important information about the company in the public domain.
6. Career prospects – employees’ assessment of the possibility of professional growth within the company.
7. Sense of security – the general level of care which the company gives to its employees.
8. Other factors – manner of employment, formality and timeliness of payments etc.

In total, the researchers interviewed more than 25 thousand people, that is every 400th employee in the country. The overall evaluation was based on the results of the survey (60%), information from public sources (20%) and the opinion of recruitment experts (20%).

“We are proud to be included in Forbes’ list of Ukraine’s 50 best employers. Our Company’s philosophy is that each Farmak employee is not just a hired specialist, but a member of a big family that we take good care of. That’s why the presence in such ratings is another indicator that we succeed,” said Viktoriia Kondrashykhina, HR Director of Farmak.

More news

Farmak’s International Office acquires Polish Symphar

As of 27 March 2024, Farmak’s International Office has successfully finalized its acquisition of Symphar, becoming the sole owner of the Polish pharmaceutical company. The acquisition represents a part of Farmak’s international expansion strategy “Farmak 2.0: From local to global success”. This M&A is an important next step after last year’s ...

Mar 28, 2024

Farmak presented its medicines at one of the largest ra...

At the beginning of March, the European Congress of Radiology (ECR) was held in Vienna, Austria. The leader of the Ukrainian pharmaceutical market*, Farmak presented at ECR contrast drugs used during magnetic resonance imaging. ECR is one of the largest medical events in Europe and the second largest radiology conference in the world. More than […]

Mar 14, 2024

Farmak employees donated more than 10 liters of blood

The pharmaceutical company Farmak took part in a two-day blood donation marathon organized by the Ministry of Justice of Ukraine. In total, the campaign managed to collect more than 315 liters of blood, more than 10 of which were donated by Farmak employees. The blood donation marathon was held jointly with the Kyiv Central Interregional […]

Feb 08, 2024